UC San Diego Health treats first cancer patient with stem-cell derived natural killer cells
Fate Therapeutics, in collaboration with UC San Diego researcher, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials. After 10… Read more »